Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
Opko, Entera share cost of 1st oral GLP-1/glucagon agonist study
Opko and Entera have formalized their partnership as the biotechs prepare to take the first oral dual agonist GLP-1/glucagon peptide into the clinic.
James Waldron
Mar 17, 2025 10:10am
Otsuka's Taiho pays $400M to buy Swiss ADC partner
Mar 17, 2025 8:10am
AstraZeneca goes in vivo, pens $1B deal for lentiviral biotech
Mar 17, 2025 7:40am
Pliant, Acelyrin take ‘poison pills’ as Concentra buyout looms
Mar 14, 2025 10:01am
Sotio takes up option on ADCs, Boehringer inks discovery pact
Mar 13, 2025 10:53am
Hologen AI commits $430M to MeiraGTx Parkinson's gene therapy
Mar 13, 2025 10:51am
